Bui, Quan M.
McCain, Julia
Allen, Larry A.
Adler, Eric D.
Anderson, Cheryl
Bloss, Cinnamon
Rabin, Borsika A.
Urey, Marcus A.
Funding for this research was provided by:
American Heart Association (24CDA1272533)
Ionis Pharmaceuticals (Janice Wiesman Young Investigator Grant)
Article History
Received: 3 July 2025
Accepted: 13 October 2025
First Online: 12 November 2025
Declarations
:
: The study was approved by the University of California, San Diego Human Research Protection Program (IRB #803384). All participants provided informed consent prior to participation in this study. This study adhered to the Declaration of Helsinki.
: Not applicable
: Larry Allen has received consulting fees from ACI Clinical, Quidel, and UpToDate, and grant funding from the NIH and PCORI. Marcus Urey has served on the advisory board and has received speaker fees from Alnylam, AstraZeneca, and BridgeBio. Marcus Urey also reports conflicts with Pfizer and has received research support for clinical trials from Ionis Pharmaceuticals and Alexion. None of the other authors have a financial relationship with a commercial entity that has an interest in the subject of the presented manuscript or other conflicts of interest to disclose.